| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.68▲ | 1.69▲ | 1.69▲ | 1.69▲ | 1.51▲ |
| MA10 | 1.68▲ | 1.66▲ | 1.65▲ | 1.61▲ | 1.41▲ |
| MA20 | 1.63▲ | 1.58▲ | 1.58▲ | 1.51▲ | 1.65▲ |
| MA50 | 1.55▲ | 1.51▲ | 1.50▲ | 1.39▲ | 3.13▼ |
| MA100 | 1.46▲ | 1.43▲ | 1.41▲ | 1.70▲ | 4.35▼ |
| MA200 | 1.53▲ | 1.67▲ | 1.80▼ | 2.81▼ | 3.49▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.010▲ | 0.012▲ | 0.026▲ | 0.146▲ |
| RSI | 64.419▲ | 65.532▲ | 66.674▲ | 70.206▲ | 42.586▼ |
| STOCH | 77.778 | 90.309▲ | 91.667▲ | 87.975▲ | 73.772 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -8.108▲ | -5.085▲ |
| CCI | 132.317▲ | 87.535 | 90.046 | 98.619 | 208.526▲ |
|
Sunday, April 12, 2026 11:55 PM
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior competing offers. Shareholders ...
|
|
Wednesday, August 06, 2025 06:58 PM
Pulmatrix’s core business has centered on developing inhaled therapies using its proprietary iSPERSE™ technology—a dry powder drug delivery platform aimed at improving medication delivery to the lungs ...
|
|
Wednesday, August 06, 2025 05:00 PM
GAAP revenue dropped to zero in Q2 2025, with no new product sales or clinical trial sponsorships. Net loss per share (GAAP) was $(0.42) in Q2 2025, reflecting significant spending cuts and a ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/07/26 | 1.74 | 1.75 | 1.58 | 1.72 | 34,615 |
| 01/07/26 | 1.71 | 1.74 | 1.63 | 1.74 | 17,776 |
| 30/06/26 | 1.57 | 1.70 | 1.57 | 1.70 | 15,183 |
| 29/06/26 | 1.56 | 1.69 | 1.52 | 1.63 | 25,493 |
| 26/06/26 | 1.69 | 1.725 | 1.61 | 1.64 | 27,444 |
| 25/06/26 | 1.54 | 1.67 | 1.51 | 1.67 | 146,846 |
| 24/06/26 | 1.47 | 1.555 | 1.46 | 1.53 | 28,242 |
| 23/06/26 | 1.52 | 1.52 | 1.44 | 1.50 | 52,643 |
| 22/06/26 | 1.46 | 1.62 | 1.4101 | 1.54 | 174,508 |
| 18/06/26 | 1.48 | 1.51 | 1.41 | 1.46 | 1,213,680 |
|
|
||||
|
|
||||
|
|